Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D001645:Biguanides / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D002784:Cholesterol / Q000097:blood; D005032:Ethylestrenol / Q000627:therapeutic use*; D005260:Female; D005340:Fibrinogen / Q000097:blood; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D008297:Male; D008687:Metformin / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D010629:Phenformin / Q000627:therapeutic use; D010919:Placebos; D014652:Vascular Diseases / Q000188:drug therapy
D001645:Biguanides; D010919:Placebos; D005340:Fibrinogen; D008687:Metformin; D002784:Cholesterol; D005032:Ethylestrenol; D010629:Phenformin